Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Jane Massey’s Story

    ...   They decided to put me on an oral medication, lenalidomide (Revlimid®) and see if that helped my blood counts. Thus far ...

    Patient Chronicle last updated 04/11/2017 - 7:29am.

  2. Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?

    ... Currently, combination therapies of azacitidine with lenalidomide appear to be promising thus making them an appealing option ...

    Research Article last updated 06/20/2013 - 11:05am.

  3. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

    ... harboring TP53 mutation do not show a good response to lenalidomide therapy. In general, the results of this study show that ...

    Research Article last updated 02/01/2017 - 8:15am.

  4. Treatment of low-risk myelodysplastic syndromes

    ... fails ESA treatment, the available options may include lenalidomide (approved for del5q positive cases), hypomethylating agents, ...

    Research Article last updated 01/26/2017 - 10:42am.

  5. Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

    ... agents, including 5-azacytidine, deoxyazacytidine, and lenalidomide . For patients no longer benefitting from these agents, there ...

    Research Article last updated 01/26/2017 - 10:36am.

  6. The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications

    ... manifested as erythroid hypoplasia. P53 antagonism by lenalidomide or other therapeutics such as antisense oligonucleotides, ...

    Research Article last updated 01/26/2017 - 10:06am.

  7. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

    ... for ESA- refractory or relapsed patients include lenalidomide , alone or in combination with ESAs; oral azacitidine ; ...

    Research Article last updated 12/09/2016 - 2:50pm.

  8. Recent developments in bone marrow transplants

    ... bone marrow transplantation. A prolonged course of lenalidomide (Revlimid, Celgene) maintenance following autologous ...

    Article last updated 11/16/2016 - 2:56pm.

  9. Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

    Journal Title:  Leukemia Primary Author:  Platzbecker U Author(s):  Platzbeck...

    Research Article last updated 02/04/2013 - 2:29pm.

  10. Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol

    ... with less than 50 % response, lasting 2 years. Aza and lenalidomide (Len) have a potential synergistic effect. ViLen-01 phase IIa ...

    Research Article last updated 09/13/2016 - 2:47pm.